Skip to main content
. Author manuscript; available in PMC: 2007 May 30.
Published in final edited form as: Nature. 2005 Oct 27;437(7063):1299–1320. doi: 10.1038/nature04226

Table 3.

HapMap Phase I genotyping success measures

Analysis panel
SNP categories YRI CEU CHB + JPT
Assays submitted 1,273,716 1,302,849 1,273,703
Passed QC filters 1,123,296 (88%) 1,157,650 (89%) 1,134,726 (89%)

Did not pass QC filters* 150,420 (12%) 145,199 (11%) 138,977 (11%)
 > 20% missing data 98,116 (65%) 107,626 (74%) 93,710 (67%)
 > 1 duplicate inconsistent 7,575 (5%) 6,254 (4%) 10,725 (8%)
 > 1 mendelian error 22,815 (15%) 13,600 (9%) 0 (0%)
 < 0.001 Hardy–Weinberg P-value 12,052 (8%) 9,721 (7%) 16,176 (12%)
 Other failures 23,478 (16%) 17,692 (12%) 23,722 (17%)

Non-redundant (unique) SNPs 1,076,392 1,104,980 1,087,305
 Monomorphic 156,290 (15%) 234,482 (21%) 268,325 (25%)
 Polymorphic 920,102 (85%) 870,498 (79%) 818,980 (75%)

All analysis panels

Unique QC-passed SNPs 1,156,772
 Passed in one analysis panel 52,204 (5%)
 Passed in two analysis panels 97,231 (8%)
 Passed in three analysis panels 1,007,337 (87%)

Monomorphic across three analysis panels 75,997
Polymorphic in all three analysis panels 682,397

MAF ≥ 0.05 in at least one of three analysis panels 877,351
*

Out of 95 samples in CEU, YRI; 94 samples in CHB + JPT.

‘Other failures’ includes SNPs with discrepancies during the data transmission process. Some SNPs failed in more than one way, so these percentages add up to more than 100%.